Pill Cuts Cholesterol 60%

RahwayThe US Food and Drug Administration approved the first oral PCSK9 pill.

Merck’s Lipfendra blocks PCSK9, a liver protein that limits LDL clearance, cutting bad cholesterol by up to 60% in trials.

Merck expects a 2029 trial readout on whether the pill also cuts heart attacks and strokes.

Sources: Aol